DORI SEVDE: Open Payments
NPI 1225595838 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 11 payments from 9 companies in 2025. Trend: 2023 $89 · 2024 $752 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $38 |
| Astellas Pharma US Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Organon LLC | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
Products named: Cologuard Collection Kit, Veozah, ENTYVIO, Ozempic, MOUNJARO, VRAYLAR, HADLIMA, ZENPEP.
Industry payments across IA — which companies pay providers there.
